Kadela-Tomanek, M.; Jastrzębska, M.; Marciniec, K.; Chrobak, E.; Bębenek, E.; Boryczka, S.
Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone. Pharmaceutics 2021, 13, 781.
https://doi.org/10.3390/pharmaceutics13060781
AMA Style
Kadela-Tomanek M, Jastrzębska M, Marciniec K, Chrobak E, Bębenek E, Boryczka S.
Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone. Pharmaceutics. 2021; 13(6):781.
https://doi.org/10.3390/pharmaceutics13060781
Chicago/Turabian Style
Kadela-Tomanek, Monika, Maria Jastrzębska, Krzysztof Marciniec, Elwira Chrobak, Ewa Bębenek, and Stanisław Boryczka.
2021. "Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone" Pharmaceutics 13, no. 6: 781.
https://doi.org/10.3390/pharmaceutics13060781
APA Style
Kadela-Tomanek, M., Jastrzębska, M., Marciniec, K., Chrobak, E., Bębenek, E., & Boryczka, S.
(2021). Lipophilicity, Pharmacokinetic Properties, and Molecular Docking Study on SARS-CoV-2 Target for Betulin Triazole Derivatives with Attached 1,4-Quinone. Pharmaceutics, 13(6), 781.
https://doi.org/10.3390/pharmaceutics13060781